CVS Health (NYSE:CVS) Issues FY20 Earnings Guidance

CVS Health (NYSE:CVS) updated its FY20 earnings guidance on Wednesday. The company provided EPS guidance of $7.04-7.17 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.15. CVS Health also updated its FY 2020
Pre-Market guidance to 7.04-7.17 EPS.

A number of equities analysts have issued reports on the company. Citigroup upped their target price on CVS Health from $83.00 to $86.00 and gave the stock a buy rating in a report on Friday. Cowen set a $76.00 target price on CVS Health and gave the stock a buy rating in a report on Monday, October 21st. Raymond James reaffirmed a strong-buy rating and issued a $90.00 target price (up previously from $80.00) on shares of CVS Health in a report on Wednesday, December 4th. ValuEngine raised CVS Health from a strong sell rating to a sell rating in a report on Friday, January 24th. Finally, Cantor Fitzgerald upped their target price on CVS Health from $85.00 to $90.00 and gave the stock an overweight rating in a report on Thursday. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. The stock has an average rating of Buy and an average price target of $78.48.

Shares of CVS stock traded down $0.63 on Friday, hitting $71.37. The company had a trading volume of 7,652,732 shares, compared to its average volume of 7,157,139. The firm has a market cap of $95.30 billion, a P/E ratio of 21.12, a P/E/G ratio of 1.56 and a beta of 0.93. The stock’s 50-day moving average is $72.71 and its two-hundred day moving average is $67.58. The company has a debt-to-equity ratio of 1.32, a quick ratio of 0.61 and a current ratio of 0.92. CVS Health has a twelve month low of $51.72 and a twelve month high of $77.03.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.73 EPS for the quarter, topping the consensus estimate of $1.68 by $0.05. CVS Health had a return on equity of 15.45% and a net margin of 1.83%. The business had revenue of $66.89 billion during the quarter, compared to analysts’ expectations of $64.01 billion. During the same quarter last year, the firm posted $2.14 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. Equities research analysts predict that CVS Health will post 7.03 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, January 22nd. This represents a $2.00 annualized dividend and a yield of 2.80%. CVS Health’s dividend payout ratio is currently 28.25%.

In related news, COO Jonathan C. Roberts sold 57,563 shares of the firm’s stock in a transaction that occurred on Wednesday, January 8th. The stock was sold at an average price of $72.63, for a total transaction of $4,180,800.69. Following the completion of the sale, the chief operating officer now owns 102,608 shares of the company’s stock, valued at $7,452,419.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Larry J. Merlo sold 266,476 shares of the firm’s stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $74.79, for a total value of $19,929,740.04. Following the sale, the chief executive officer now directly owns 703,497 shares of the company’s stock, valued at approximately $52,614,540.63. The disclosure for this sale can be found here. Insiders have sold 404,182 shares of company stock valued at $30,121,266 in the last ninety days. 0.53% of the stock is currently owned by insiders.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Read More: Percentage Gainers

Earnings History and Estimates for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.